Dr. Henry C Pitot
Claim this profileArea of expertise
Solid Tumors
Henry C Pitot has run 1 trial for Solid Tumors. Some of their research focus areas include:
More about Henry C Pitot
Clinical Trial Related
23 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Henry C Pitot has experience with
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
Breakdown of trials Henry C Pitot has run
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Henry C Pitot specialize in?
Henry C Pitot focuses on Solid Tumors and other conditions. In particular, much of their work with Solid Tumors has involved EGFR positive patients, or patients who are UGT1A1 positive.
Is Henry C Pitot currently recruiting for clinical trials?
No, Henry C Pitot is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Henry C Pitot has studied deeply?
Yes, Henry C Pitot has studied treatments such as Erlotinib Hydrochloride, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Henry C Pitot?
Apply for one of the trials that Henry C Pitot is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.